Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) Equity Average (2017 - 2025)

Bioceres Crop Solutions' Equity Average history spans 8 years, with the latest figure at $290.2 million for Q2 2025.

  • For Q2 2025, Equity Average fell 10.08% year-over-year to $290.2 million; the TTM value through Jun 2025 reached $290.2 million, down 10.08%, while the annual FY2025 figure was $290.2 million, 10.08% down from the prior year.
  • Equity Average for Q2 2025 was $290.2 million at Bioceres Crop Solutions, down from $322.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $322.8 million in Q2 2024 and bottomed at -$133.5 million in Q4 2021.
  • The 5-year median for Equity Average is $160.0 million (2021), against an average of $116.6 million.
  • The largest annual shift saw Equity Average tumbled 231.8% in 2022 before it soared 345.54% in 2023.
  • A 5-year view of Equity Average shows it stood at -$133.5 million in 2021, then increased by 25.46% to -$99.5 million in 2022, then skyrocketed by 345.54% to $244.4 million in 2023, then soared by 32.07% to $322.8 million in 2024, then decreased by 10.08% to $290.2 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Equity Average are $290.2 million (Q2 2025), $322.8 million (Q2 2024), and $244.4 million (Q2 2023).